Article Text

Download PDFPDF

Adolescents need a booster of serogroup C meningococcal vaccine to protect them and maintain population control of the disease

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors All authors contributed equally in the formulation of the manuscript and the review of the final draft.

  • Competing interests AJP and MDS conduct clinical trials on behalf of Oxford University sponsored by manufacturers of meningococcal vaccines but do not receive any personal payments from them. Honoraria and travel reimbursement for attendance at conferences and advisory board meetings by MDS are paid to a fund held at the University. The University receives unrestricted educational grants from these manufacturers for organisation of conferences and symposia. AJP is a member of the meningococcal subcommittee of the Joint Committee of Vaccination and Immunisation.

  • Provenance and peer review Commissioned; externally peer reviewed.